---
figid: PMC9360899__ajtr0014-4426-f1
figtitle: PI3K/AKT signaling pathway in gallbladder carcinoma
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9360899
filename: ajtr0014-4426-f1.jpg
figlink: /pmc/articles/PMC9360899/figure/fig01/
number: F1
caption: Many RNAs, proteins, and drugs can directly or indirectly interact with the
  PI3K/AKT pathway, exerting their respective carcinogenic or anticancer effects.
  PTEN is a tumor suppressor and its inactivation can lead to carcinogenesis. UBR5,
  which is a key regulator of the ubiquitin-proteasome system, can inactivate PTEN
  by ubiquitination. In contrast, DMBT1 can directly bind with and stabilize PTEN
  to reverse the phosphorylation of AKT. Furthermore, LINC00152 can function as a
  cancer promotor by directly producing p-AKT and p-PI3K without changing the number
  of PI3K and AKT.
papertitle: The role of PI3K/AKT signaling pathway in gallbladder carcinoma.
reftext: Zeyu Wu, et al. Am J Transl Res. 2022;14(7):4426-4442.
year: '2022'
doi: ''
journal_title: American Journal of Translational Research
journal_nlm_ta: Am J Transl Res
publisher_name: e-Century Publishing Corporation
keywords: PI3K/AKT pathway | gallbladder cancer | crosstalk | regulation | mechanism
  | protein | chemotherapeutic agent
automl_pathway: 0.9519373
figid_alias: PMC9360899__F1
figtype: Figure
redirect_from: /figures/PMC9360899__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9360899__ajtr0014-4426-f1.html
  '@type': Dataset
  description: Many RNAs, proteins, and drugs can directly or indirectly interact
    with the PI3K/AKT pathway, exerting their respective carcinogenic or anticancer
    effects. PTEN is a tumor suppressor and its inactivation can lead to carcinogenesis.
    UBR5, which is a key regulator of the ubiquitin-proteasome system, can inactivate
    PTEN by ubiquitination. In contrast, DMBT1 can directly bind with and stabilize
    PTEN to reverse the phosphorylation of AKT. Furthermore, LINC00152 can function
    as a cancer promotor by directly producing p-AKT and p-PI3K without changing the
    number of PI3K and AKT.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LARGE1
  - EGFR
  - SP1
  - PSG1
  - DAND5
  - CYTOR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - DMBT1
  - AKT1
  - AKT2
  - AKT3
  - UTP25
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - ATP8A2
  - APRT
  - MFAP1
  - Egfr
  - Sce
  - Sp1
  - grass
  - Spn42Dd
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - Akt
  - Def
  - amon
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - ATPsynbeta
  - Atpalpha
  - CG11700
  - Amph
---
